Journal of Addiction Medicine

Papers
(The H4-Index of Journal of Addiction Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language76
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations53
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions41
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.41
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine38
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–201937
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report36
Letter to the Editor (RE: Polles et al)35
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails32
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial28
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes26
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease25
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations25
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation25
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder24
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder23
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study23
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era23
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study22
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review21
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals21
0.078510046005249